A detailed history of Nine Point Two Capital LLC transactions in Johnson & Johnson stock. As of the latest transaction made, Nine Point Two Capital LLC holds 3,402 shares of JNJ stock, worth $525,677. This represents 0.21% of its overall portfolio holdings.

Number of Shares
3,402
Previous 3,402 -0.0%
Holding current value
$525,677
Previous $529,000 0.76%
% of portfolio
0.21%
Previous 0.22%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$151.05 - $180.26 $15,860 - $18,927
-105 Reduced 2.99%
3,402 $527,000
Q4 2022

Feb 14, 2023

BUY
$160.2 - $179.79 $160,200 - $179,790
1,000 Added 39.89%
3,507 $619,000
Q2 2022

Aug 15, 2022

BUY
$168.19 - $186.01 $17,659 - $19,531
105 Added 4.37%
2,507 $445,000
Q4 2020

Feb 17, 2021

BUY
$137.11 - $157.38 $329,338 - $378,026
2,402 New
2,402 $378,000

Others Institutions Holding JNJ

About JOHNSON & JOHNSON


  • Ticker JNJ
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,614,479,872
  • Market Cap $404B
  • Description
  • Johnson & Johnson, together with its subsidiaries, researches and develops, manufactures, and sells various products in the healthcare field worldwide. The company's Consumer Health segment offers baby care products under the JOHNSON'S and AVEENO Baby brands; oral care products under the LISTERINE brand; skin health/beauty products under the...
More about JNJ
Track This Portfolio

Track Nine Point Two Capital LLC Portfolio

Follow Nine Point Two Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Nine Point Two Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nine Point Two Capital LLC with notifications on news.